CoChat
Sign Up
Cited by 223Endometriosis Research and TreatmentEctopic Pregnancy Diagnosis and ManagementGynecological conditions and treatments

Randomized Controlled Trial of Depot Leuprolide in Patients With Chronic Pelvic Pain and Clinically Suspected Endometriosis

LING, FRANK W.·1999·Obstetrics & Gynecology
DOI 10.1097/00006250-199901000-00012
Open this paper in CoChat — free account

Abstract

In Brief Objective To evaluate and compare the safety and efficacy of leuprolide versus placebo in managing chronic pelvic pain in women with clinically suspected endometriosis. Methods Women 18–45 years of age with moderate to severe pelvic pain of at least 6 months' duration underwent extensive, noninvasive diagnostic testing and laboratory evaluation, including pelvic ultrasound, complete blood count, determination of erythrocyte sedimentation rate, and endocervical cultures. Those with clinically suspected endometriosis were randomized to double-blind treatment for 3 months with depot leuprolide (3.75 mg/mo) or placebo. The accuracy of the clinical diagnosis of endometriosis was evaluated by posttreatment laparoscopy. Results Of 100 women randomized, 95 completed the study: 49 in the leuprolide group and 46 in the placebo group. Women in the leuprolide group had clinically and statistically significant (P ≤ .001) mean improvements from baseline after 12 weeks of therapy in all pain measures. These mean improvements were significantly greater (P ≤ .001) than those in the placebo group. At 12 weeks, mean decreases in physician-rated scores for dysmenorrhea, pelvic pain, and pelvic tenderness were 1.7, 1.0, and 0.8 points greater, respectively, in the leuprolide group than in the placebo group (on a four-point scale). Thirty-eight (78%) of 49 and 40 (87%) of 46 patients in the leuprolide and placebo groups, respectively, had laparoscopically confirmed endometriosis after 12 weeks of treatment. No women withdrew from the study because of adverse events. Conclusion Depot leuprolide was effective and safe for treating patients with chronic pelvic pain and clinically suspected endometriosis, confirming the potential of its empiric use in these patients. Depot leuprolide is effective in treating chronic pelvic pain in women with suspected endometriosis.

Integrity signals

Registry

Crossref · 10.1097/00006250-199901000-00012

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In a randomised controlled trial designed to evaluate the efficacy of leuprolide against placebo in the management of chronic pelvic pain among women with clinically diagnosed endometriosis, post-treatment laparoscopy confirmed 78% and 87% of clinically diagnosed cases in the leuprolide and placebo groups, respectively.

    “Second, in a randomised controlled trial designed to evaluate the efficacy of leuprolide against placebo in the management of chronic pelvic pain among women with clinically diagnosed endometriosis, post-treatment laparoscopy confirmed 78% and 87% of clinically diagnosed cases in the leuprolide and placebo groups, respectively. 41”

    From Risk of cardiovascular outcomes among women with endometriosis in the United Kingdom: a retrospective matched cohort study (2021) · cites this paper as [41]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Related

Authors
LING, F. W.
Affiliations
University of Tennessee Health Science Center (US)
Corresponding author
LING, FRANK W.
Venue
Obstetrics & Gynecology
Publisher
Ovid Technologies (Wolters Kluwer Health)
Published
1999-01
Volume
93
Issue
1
Pages
51-58
ISSN
0029-7844 (ISSN-L)
DOI
10.1097/00006250-199901000-00012
OpenAlex
W2145262010
Cited by
223
References
22
Citations by year
2026: 1 · 2025: 3 · 2024: 1 · 2023: 2 · 2022: 4 · 2021: 6 · 2020: 8 · 2019: 4 · 2018: 8 · 2017: 4 · 2016: 7 · 2015: 10 · 2014: 13 · 2013: 11 · 2012: 13
FWCI
6.78
Type
journal article
Language
en
Open access
closed
Locations
  • Obstetrics and Gynecology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Ectopic Pregnancy Diagnosis and Management
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gynecological conditions and treatments
Keywords
chronic pelvic pain, endometriosis, dysmenorrhea, GnRH agonist therapy, laparoscopic confirmation
MeSH terms
Adolescent, Adult, Algorithms, Chronic Disease, Delayed-Action Preparations, Double-Blind Method, Endometriosis, Female, Humans, Middle Aged, Laparoscopy, Leuprolide, Pelvic Pain

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review